Literature DB >> 24653580

p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats.

QinHe Yang1, YongJian Xu1, GaoFei Feng1, ChaoFeng Hu2, YuPei Zhang1, ShaoBing Cheng1, YanPing Wang2, XiangWen Gong1.   

Abstract

BACKGROUND: Traditional Chinese Medicine (TCM), has over thousands-of-years history of use. Chaihu-Shugan-San (CSS), and Shen-ling-bai-zhu-San (SLBZS), are famous traditional Chinese herbal medicine formulas, which have been used in China, for the treatment of many chronic diseases.
MATERIALS AND METHODS: This study investigated the anti-inflammatory effects of CSS and SLBZS on signaling molecules involved in p38 mitogen-activated protein kinase (p38 MAPK), pathway on hepatocytes of non-alcoholic steatohepatitis (NASH), rats induced by high fat diet. SD male rats were randomly divided into 8 groups: negative control group, model control group, high (9.6g/kg/day)/low (3.2g/kg/day)-dose CSS group, high (30g/kg/day)/low (10g/kg/day)-dose SLBZS group, high (39.6g/kg/day)/low (13.2g/kg/day)-dose integrated group. The rats of NASH model were induced by feeding a high-fat diet. After 16, wks, Hepatocytes were isolated from 6, rats in each group by collagenase perfusion. The liver histopathological changes and serum inflammatory cytokines TNF-α, IL-6 were determined. The proteins of TLR4, phosphor-p38 MAPK and p38 MAPK involved in p38 MAPK signal pathway were assayed.
RESULTS: The statistical data indicated the NASH model rats reproduced typical histopathological features of NASH in human. CSS and SLBZS ameliorated lipid metabolic disturbance, attenuated NASH progression, decreased the levels of TNF-α and IL-6 in serum, as well as inhibited TLR4 protein expression, p38 MAPK phosphorylation, and activation of p38 MAPK. In conclusion, CSS and SLBZS might work as a significant anti-inflammatory effect on hepatocyte of NASH by inhibiting the activation of TLR4, p-p38 MAPK and p38 MAPK involved in p38 MAPK signal pathway.
CONCLUSION: To some extent, CSS and SLBZS may be a potential alternative and complementary medicine to protect against liver injury, alleviate the inflammation reaction, moderate NASH progression.

Entities:  

Keywords:  Chaihu-Shugan-San (CSS); Hepatocytes; Non-alcoholic Steatohepatitis; Shen-ling-bai-zhu-San (SLBZS); Toll like receptor 4; Traditional Chinese medicine; p38 mitogen-activated protein kinase

Mesh:

Substances:

Year:  2013        PMID: 24653580      PMCID: PMC3957268          DOI: 10.4314/ajtcam.v11i1.34

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  24 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 2.  TLR signaling pathways.

Authors:  Kiyoshi Takeda; Shizuo Akira
Journal:  Semin Immunol       Date:  2004-02       Impact factor: 11.130

3.  A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.

Authors:  Hiroaki Furumaki; Shiho Matsuoka; Toshihiro Sakurai; Masashi Kohanawa; Songji Zhao; Yuji Kuge; Nagara Tamaki; Hitoshi Chiba
Journal:  Lab Invest       Date:  2011-11-07       Impact factor: 5.662

4.  Hydroxyethyl starch (130 kD) inhibits Toll-like receptor 4 signaling pathways in rat lungs challenged with lipopolysaccharide.

Authors:  Jie Tian; Yunxia Wang; Zhengyu He; Yuan Gao; Joyce E Rundhaug; Xiangrui Wang
Journal:  Anesth Analg       Date:  2011-03-17       Impact factor: 5.108

5.  [Protective effect of atractylenolide I on immunological liver injury].

Authors:  Changhe Wang; Qingguang Geng; Yuxuan Wang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2012-06

Review 6.  From the metabolic syndrome to NAFLD or vice versa?

Authors:  Ester Vanni; Elisabetta Bugianesi; Anna Kotronen; Samuele De Minicis; Hannele Yki-Järvinen; Gianluca Svegliati-Baroni
Journal:  Dig Liver Dis       Date:  2010-03-06       Impact factor: 4.088

7.  Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.

Authors:  Guiyuan Ji; Qinhe Yang; Jing Hao; Lina Guo; Xiang Chen; Jianping Hu; Liang Leng; Zhuoqin Jiang
Journal:  Int Immunopharmacol       Date:  2011-02-12       Impact factor: 4.932

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

9.  Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model.

Authors:  Hiroshi Kudo; Terumi Takahara; Yutaka Yata; Kengo Kawai; Wei Zhang; Toshiro Sugiyama
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

10.  Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target.

Authors:  Michael Fuchs
Journal:  J Lipids       Date:  2011-12-07
View more
  15 in total

1.  Electroacupuncture Attenuated Phenotype Transformation of Vascular Smooth Muscle Cells via PI3K/Akt and MAPK Signaling Pathways in Spontaneous Hypertensive Rats.

Authors:  Xin-Yu Chen; Lu-Ping Yang; Ya-Ling Zheng; Yu-Xi Li; Dong-Ling Zhong; Rong-Jiang Jin; Juan Li
Journal:  Chin J Integr Med       Date:  2021-11-28       Impact factor: 1.978

2.  Anti-inflammatory Effect of a Limonin Derivative In Vivo and Its Mechanisms in RAW264.7 Cells.

Authors:  Ning Wang; Xiao Chen; Yingying Ji; Tian Lan; Wei Yan; Yungen Xu; Guoqing Gong
Journal:  Inflammation       Date:  2022-08-20       Impact factor: 4.657

3.  Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage.

Authors:  Feng-Sen Li; Yan-Li Zhang; Zheng Li; Dan Xu; Chun-Yan Liao; Huan Ma; Li Gong; Jun Su; Qi Sun; Qian Xu; Zhen Gao; Ling Wang; Jing Jing; Jing Wang; Min Jiang; Ge Tian; Bilal Hasan
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

4.  Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice.

Authors:  Yi Zhang; Hong An; Si-Yuan Pan; Dan-Dan Zhao; Jia-Cheng Zuo; Xiao-Ke Li; Ya Gao; Qian-Qian Mu; Na Yu; Yue Ma; Fang-Fang Mo; Si-Hua Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-21       Impact factor: 2.629

Review 5.  Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.

Authors:  Cong Liu; Jia-Zhi Liao; Pei-Yuan Li
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

6.  The Herb-Drug Pharmacokinetic Interaction of Fluoxetine and Its Metabolite Norfluoxetine with a Traditional Chinese Medicine in Rats by LC-MS/MS.

Authors:  Lijing Yan; Sheng Wang; Linlin Zhao; Juan Qiu; Lu Zhou; Wenbo Wang; Xia Xu; Dongsheng Wang; Xinjian Qiu; Dilan Qin
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-30       Impact factor: 2.629

Review 7.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

8.  A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.

Authors:  Huan Nie; Yuanjun Deng; Chuiyang Zheng; Maoxing Pan; Jiqian Xie; Yupei Zhang; Qinhe Yang
Journal:  J Cell Mol Med       Date:  2020-03-18       Impact factor: 5.310

9.  Shen-ling-bai-zhu-san ameliorates inflammation and lung injury by increasing the gut microbiota in the murine model of Streptococcus pneumonia-induced pneumonia.

Authors:  Jinli Feng; Weibo Dai; Cheng Zhang; Houjun Chen; Ziliang Chen; Yongfeng Chen; Qianyi Pan; Yongmao Zhou
Journal:  BMC Complement Med Ther       Date:  2020-05-27

10.  Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex.

Authors:  Lijing Yan; Xia Xu; Zhenyu He; Sheng Wang; Linlin Zhao; Juan Qiu; Dongsheng Wang; Zhicheng Gong; Xinjian Qiu; Huiyong Huang
Journal:  Biomed Res Int       Date:  2020-02-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.